US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.1031
  • -0.0005-0.48%
Close Aug 23 16:00 ET
  • 0.1032
  • +0.0001+0.10%
Post 19:57 ET
25.86MMarket Cap-937P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Q2 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.02
-0.02
+<0.01
Beat Est.
+16.72%
+33.33%
+19.68%
Analyst Rating
Buy

Jul 31, 2024

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 27, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 27, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Matinas BioPharma Earnings Reports

  • Matinas BioPharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:53 ET

  • Matinas BioPharma | 10-Q: Q1 2024 Earnings Report

    May 9 16:04 ET

  • Matinas BioPharma | 10-K: FY2023 Annual Report

    Mar 27 16:06 ET

  • Matinas BioPharma | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg